Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Off-label drugs for weight management.

Hendricks EJ.

Diabetes Metab Syndr Obes. 2017 Jun 10;10:223-234. doi: 10.2147/DMSO.S95299. eCollection 2017. Review.

2.

Weight management in obesity - past and present.

Haslam D.

Int J Clin Pract. 2016 Mar;70(3):206-17. doi: 10.1111/ijcp.12771. Epub 2016 Jan 26. Review.

3.

Next generation of weight management medications: implications for diabetes and CVD risk.

Wharton S, Serodio KJ.

Curr Cardiol Rep. 2015 May;17(5):35. doi: 10.1007/s11886-015-0590-z. Review.

4.

Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity.

Joharapurkar AA, Dhanesha NA, Jain MR.

Diabetes Metab Syndr Obes. 2014 Feb 28;7:73-84. doi: 10.2147/DMSO.S56924. eCollection 2014. Review.

5.

Pharmacotherapy for childhood obesity: present and future prospects.

Sherafat-Kazemzadeh R, Yanovski SZ, Yanovski JA.

Int J Obes (Lond). 2013 Jan;37(1):1-15. doi: 10.1038/ijo.2012.144. Epub 2012 Aug 28. Review.

6.

Pharmacological management of binge eating disorder: current and emerging treatment options.

McElroy SL, Guerdjikova AI, Mori N, O'Melia AM.

Ther Clin Risk Manag. 2012;8:219-41. doi: 10.2147/TCRM.S25574. Epub 2012 May 8.

7.

Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults.

Gibson CD, Karmally W, McMahon DJ, Wardlaw SL, Korner J.

Diabetes Obes Metab. 2012 Apr;14(4):335-40. doi: 10.1111/j.1463-1326.2011.01534.x. Epub 2011 Dec 27.

8.

Treatment options for obesity and potential therapies on the horizon.

Motycka CA, St Onge E, Miller SA.

P T. 2011 May;36(5):282-301. No abstract available.

9.

Imaging of brain dopamine pathways: implications for understanding obesity.

Wang GJ, Volkow ND, Thanos PK, Fowler JS.

J Addict Med. 2009 Mar;3(1):8-18. doi: 10.1097/ADM.0b013e31819a86f7.

10.

Pharmacotherapies for obesity: past, current, and future therapies.

Ioannides-Demos LL, Piccenna L, McNeil JJ.

J Obes. 2011;2011:179674. doi: 10.1155/2011/179674. Epub 2010 Dec 12.

11.

Drugs in the pipeline for the obesity market.

Klonoff DC, Greenway F.

J Diabetes Sci Technol. 2008 Sep;2(5):913-8.

12.

Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature.

Zaccara G, Specchio LM.

Neuropsychiatr Dis Treat. 2009;5:249-59. Epub 2009 May 20.

13.

Combination pharmaceutical therapies for obesity.

Gadde KM, Allison DB.

Expert Opin Pharmacother. 2009 Apr;10(6):921-5. doi: 10.1517/14656560902824152 .

Supplemental Content

Support Center